These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36207132)

  • 1. Clinical benefits of therapeutic drug monitoring of vancomycin therapy in patients with postoperative intracerebral hemorrhage: a retrospective cohort study.
    Liu H; Yang H; Guo X; Bai Y; SiRi G
    Eur J Hosp Pharm; 2024 Apr; 31(3):240-246. PubMed ID: 36207132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital in Singapore.
    Seng JJB; Yong MHA; Peh ZX; Soong JL; Tan MH
    Int J Clin Pharm; 2018 Oct; 40(5):977-981. PubMed ID: 29948742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
    Ye ZK; Tang HL; Zhai SD
    PLoS One; 2013; 8(10):e77169. PubMed ID: 24204764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
    Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
    J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vancomycin therapeutic drug monitoring on patient care.
    Welty TE; Copa AK
    Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
    Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
    J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
    Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
    J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of vancomycin in neurosurgery patients, from trough concentration to area under the curve: a retrospective single center cohort study in a tertiary hospital.
    Chen Y; Kong X; Liu L
    J Int Med Res; 2022 Mar; 50(3):3000605221083242. PubMed ID: 35264048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Fernández de Gatta MD; Calvo MV; Hernández JM; Caballero D; San Miguel JF; Domínguez-Gil A
    Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis.
    Zhang X; Wu Y; Wang D
    BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.
    Iwamoto T; Kagawa Y; Kojima M
    Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Serum C-reactive Protein Level as a Predictor of Increasing Serum Vancomycin Concentration During Treatment.
    Isoda K; Nakade J; Suga Y; Fujita A; Shimada T; Sai Y
    Ther Drug Monit; 2021 Oct; 43(5):652-656. PubMed ID: 33538550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis.
    Mader MM; Czorlich P; König C; Fuhrmann V; Kluge S; Westphal M; Grensemann J
    Acta Neurochir (Wien); 2018 Nov; 160(11):2099-2105. PubMed ID: 30242495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy].
    Imai S; Yamada T; Ishiguro N; Miyamoto T; Kagami K; Tomiyama N; Niinuma Y; Nagasaki D; Suzuki K; Yamagami A; Kasashi K; Kobayashi M; Iseki K
    Yakugaku Zasshi; 2017; 137(9):1185-1192. PubMed ID: 28867705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
    Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
    Oda K; Jono H; Nosaka K; Saito H
    Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort.
    Al-Maqbali JS; Shukri ZA; Sabahi NA; Al-Riyami I; Al Alawi AM
    J Infect Public Health; 2022 May; 15(5):589-593. PubMed ID: 35500543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.